Prevention of CNS seeding early in the metastatic disease course using drugs with both intra- and extracranial activity will be crucial to improving outcomes in patients with breast cancer brain metastases.
Shalu Pahuja, MD
Advertisement
Articles by Shalu Pahuja, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
2
Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma
3
What Does an End-of-Life Doula Do for Patients With Cancer?
4
GLP-1 Receptor Agonists and Cancer: Renewed Momentum for Metabo-Oncology
5